If you’re looking for free certifications for remote jobs, you’ve come to the right place! In today’s increasingly digital world, securing a remote job is more competitive than ever. However, one way ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

On 22 April 2026, U.S. House Energy and Commerce Committee Vice Chairman John Joyce, R-Pa., introduced a long-awaited comprehensive consumer privacy bill, HR 8413 ...

Excel is full of answers. They’re just not always easy to see. You open a spreadsheet and there it is: rows of numbers, dates, categories, totals. You know there’s something useful there. A trend. A ...

Several key tech companies signed a nonbinding pledge at the White House on Wednesday that the Trump administration claims will ensure that tech companies do not pass the cost of data centers on to ...

Abstract: Social media platforms, particularly Twitter, have become vital sources for understanding public sentiment due to the rapid, large-scale generation of user opinions. Sentiment analysis of ...

In today’s data-rich environment, business are always looking for a way to capitalize on available data for new insights and increased efficiencies. Given the escalating volumes of data and the ...

The funding covers more than half of the A.I. data centers that OpenAI plans to build in the U.S. over the next several years. By Cade Metz Reporting from San Francisco OpenAI has signed a deal with ...

If you’d like an LLM to act more like a partner than a tool, Databot is an experimental alternative to querychat that also works in both R and Python. Databot is designed to analyze data you’ve ...

What if you could turn Excel into a powerhouse for advanced data analysis and automation in just a few clicks? Imagine effortlessly cleaning messy datasets, running complex calculations, or generating ...

ABSTRACT: Evaluating drug safety during pregnancy remains an ongoing clinical and pharmacological challenge due to ethical, practical, and regulatory barriers, resulting in scarce human clinical trial ...